{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"grade-iii-lymphomatoid-granulomatosis","columns":[{"gene":"","key":"population-0cc36791d3cfff01ebe3","label":"grade III lymphomatoid granulomatosis","mondoId":"MONDO:0859749","onsetQualifier":null,"originColumnKey":"MONDO:0859749/no-native-evidence","originalViews":[{"key":"MONDO:0859749/no-native-evidence","label":"grade III lymphomatoid granulomatosis","scopeLabel":"No safely mapped HPO entry","sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"recordKeys":[],"recordQualifiers":{},"scopeLabel":"No safely mapped HPO entry","sourceIds":[],"sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-0cc36791d3cfff01ebe3"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":["population-0cc36791d3cfff01ebe3"],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Grade III lymphomatoid granulomatosis is a high-grade form of an Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorder.","mondoId":"MONDO:0859749","node":{"canonicalSlug":"grade-iii-lymphomatoid-granulomatosis","comparisons":[{"documentSha256":"82b9d7d66fb4babefb26e844950ee36a7dd8627565ca35cf9151cfec05b08424","key":"expanded-aggressive-b-cell-non-hodgkin-lymphoma","kind":"expanded","label":"aggressive B-cell non-Hodgkin lymphoma","memberIds":["MONDO:0000814","MONDO:0000872","MONDO:0000901","MONDO:0006117","MONDO:0006150","MONDO:0006158","MONDO:0006223","MONDO:0006225","MONDO:0006268","MONDO:0006383","MONDO:0006387","MONDO:0006416","MONDO:0006417","MONDO:0006428","MONDO:0006430","MONDO:0006462","MONDO:0007243","MONDO:0017346","MONDO:0017347","MONDO:0017595","MONDO:0017596","MONDO:0017597","MONDO:0017601","MONDO:0018225","MONDO:0018813","MONDO:0018842","MONDO:0018876","MONDO:0018905","MONDO:0019461","MONDO:0019466","MONDO:0020323","MONDO:0020324","MONDO:0020511","MONDO:0044889","MONDO:0850418","MONDO:0850419","MONDO:0850468","MONDO:0850469","MONDO:0850470","MONDO:0850471","MONDO:0850472","MONDO:0850473","MONDO:0859747","MONDO:0859748","MONDO:0859749","MONDO:0956987","MONDO:0956988","MONDO:0979292"],"mondoId":"MONDO:0017595","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-82b9d7d66fb4babefb26.82b9d7d66fb4babefb26e844950ee36a7dd8627565ca35cf9151cfec05b08424.json"},{"documentSha256":"887631938b2632c3927ccd7f92c34dc86dad319ac4b26b6d8333ce3d460b1cb6","key":"expanded-epstein-barr-virus-related-tumor","kind":"expanded","label":"Epstein-Barr virus-related tumor","memberIds":["MONDO:0001892","MONDO:0002159","MONDO:0002571","MONDO:0002624","MONDO:0003347","MONDO:0003348","MONDO:0003349","MONDO:0003350","MONDO:0003351","MONDO:0003353","MONDO:0003355","MONDO:0003356","MONDO:0003357","MONDO:0003358","MONDO:0003359","MONDO:0003360","MONDO:0003362","MONDO:0003364","MONDO:0003365","MONDO:0003367","MONDO:0003368","MONDO:0003369","MONDO:0003370","MONDO:0003371","MONDO:0003372","MONDO:0003373","MONDO:0003374","MONDO:0003376","MONDO:0003377","MONDO:0003378","MONDO:0003379","MONDO:0003655","MONDO:0003782","MONDO:0003928","MONDO:0004206","MONDO:0004207","MONDO:0004208","MONDO:0004604","MONDO:0004620","MONDO:0004633","MONDO:0004665","MONDO:0004952","MONDO:0005058","MONDO:0005764","MONDO:0006128","MONDO:0006150","MONDO:0006416","MONDO:0006429","MONDO:0007243","MONDO:0009348","MONDO:0010273","MONDO:0010762","MONDO:0015459","MONDO:0016262","MONDO:0016283","MONDO:0017342","MONDO:0017343","MONDO:0017344","MONDO:0017345","MONDO:0017346","MONDO:0017347","MONDO:0017348","MONDO:0017349","MONDO:0017596","MONDO:0017601","MONDO:0017784","MONDO:0018223","MONDO:0018224","MONDO:0018842","MONDO:0019466","MONDO:0019472","MONDO:0019478","MONDO:0021297","MONDO:0021537","MONDO:0044778","MONDO:0044887","MONDO:0859747","MONDO:0859748","MONDO:0859749"],"mondoId":"MONDO:0017342","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-887631938b2632c3927c.887631938b2632c3927ccd7f92c34dc86dad319ac4b26b6d8333ce3d460b1cb6.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"reviewed-summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Grade III lymphomatoid granulomatosis","originalSourceId":null,"paragraphs":["Grade III lymphomatoid granulomatosis is a high-grade form of an Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorder.","Broader context: lymphomatoid granulomatosis can affect the lungs, skin and central nervous system. These general features do not provide grade III-specific frequency estimates."],"rawAttribution":"MONDO:0859749","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:43:31Z","upstream":"MONDO:0859749","url":"https://rarediseases.info.nih.gov/diseases/26761"},"ownColumnKeys":["population-0cc36791d3cfff01ebe3"],"publication":"published","relationships":[{"kind":"parent","label":"lymphomatoid granulomatosis","mondoId":"MONDO:0019466","slug":"lymphomatoid-granulomatosis"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published","editorialReview":{"reviewedAt":"2026-10-26","decision":"corrected","reason":"Use the grade-specific identity and label general LG features as broader context. Remove the unsupported classification of associated conditions as immunodeficiency states.","sources":["https://seer.cancer.gov/seertools/hemelymph/5a7de1b21ef557f9c862cea7/"],"originalNarrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Grade III lymphomatoid granulomatosis","originalSourceId":null,"paragraphs":["Lymphomatoid granulomatosis (LG) is a rare, progressive malignant neoplastic disease in adults and children (although it is most common in individuals in the fifth and sixth decade), where nodular lesions destroy blood vessels. In addition, the lungs are usually affected. LG is composed of B-cells positive for Epstein-Barr virus (EBV) and mixed with reactive T-cells. It often occurs in association with an underlying immunodeficiency state such as rheumatoid arthritis, organ transplantation, and human immune deficiency virus (HIV) infection. A grading system from Grade I to Grade III for LG is based on the number of atypical lymphocytes, EBV-positive B-cells, and amount of tissue destruction (necrosis). The advanced form (grade III) of LG is approached clinically as a subtype of diffuse large B-cell non-Hodgkin lymphoma (NHL). The clinical features reflect systemic multi-organ disease with lung, skin, and central nervous system (CNS) involvement."],"rawAttribution":"MONDO:0859749","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:43:31Z","upstream":"MONDO:0859749","url":"https://rarediseases.info.nih.gov/diseases/26761"},"claimHolds":[]}},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/26761\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0859749\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0859749</dd></dl></details><p class=\"section-source\">Source clarification. <a href=\"https://seer.cancer.gov/seertools/hemelymph/5a7de1b21ef557f9c862cea7/\" rel=\"noreferrer\">1</a></p>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Grade III lymphomatoid granulomatosis is a high-grade form of an Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorder.</p><p>Broader context: lymphomatoid granulomatosis can affect the lungs, skin and central nervous system. These general features do not provide grade III-specific frequency estimates.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/26761\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"grade-iii-lymphomatoid-granulomatosis","sourceDocuments":[{"name":"GARD: Grade III lymphomatoid granulomatosis","reviewed":null,"source_release":"2026-10-25T03:43:31Z","url":"https://rarediseases.info.nih.gov/diseases/26761"},{"name":"MONDO: grade III lymphomatoid granulomatosis","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0859749"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"grade III lymphomatoid granulomatosis"},"schemaVersion":1}
